DK1432407T3 - Lisinoprilpræparater, der har DCPD med store partikler - Google Patents

Lisinoprilpræparater, der har DCPD med store partikler

Info

Publication number: DK1432407T3
Authority: DK; Denmark
Prior art keywords: lisinopril; dcpd; preparations; large particles; composition
Prior art date: 2001-09-24

Application number

DK02758654T

Other languages

English (en)

Inventor

Ronald John Roberts

David Brandon Bowen

Original Assignee

Astrazeneca Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-24

Filing date

2002-09-20

Publication date

2005-05-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25505851&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1432407(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-20 Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd

2005-05-23 Application granted granted Critical

2005-05-23 Publication of DK1432407T3 publication Critical patent/DK1432407T3/da

Links

108010007859 Lisinopril Proteins 0.000 title abstract 6
229960002394 lisinopril Drugs 0.000 title abstract 6
RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 title abstract 3
239000002245 particle Substances 0.000 title abstract 2
HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical compound C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 abstract 5
CZRQXSDBMCMPNJ-ZUIPZQNBSA-N lisinopril dihydrate Chemical compound O.O.C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 CZRQXSDBMCMPNJ-ZUIPZQNBSA-N 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000007857 degradation product Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Inorganic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

DK02758654T 2001-09-24 2002-09-20 Lisinoprilpræparater, der har DCPD med store partikler DK1432407T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/962,429 US6462022B1 (en)	2001-09-24	2001-09-24	Lisinopril compositions having large-particle DCPD
PCT/GB2002/004292 WO2003026622A1 (en)	2001-09-24	2002-09-20	Lisinopril compositions having large-particle dcpd

Publications (1)

Publication Number	Publication Date
DK1432407T3 true DK1432407T3 (da)	2005-05-23

Family

ID=25505851

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02758654T DK1432407T3 (da)	2001-09-24	2002-09-20	Lisinoprilpræparater, der har DCPD med store partikler

Country Status (10)

Country	Link
US (1)	US6462022B1 (da)
EP (1)	EP1432407B2 (da)
JP (1)	JP4084749B2 (da)
AT (1)	ATE290370T1 (da)
DE (1)	DE60203192T3 (da)
DK (1)	DK1432407T3 (da)
ES (1)	ES2236561T5 (da)
GB (1)	GB2384429B (da)
PT (1)	PT1432407E (da)
WO (1)	WO2003026622A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070196477A1 (en) *	2004-04-30	2007-08-23	Withiam Michael C	Rapidly dissolving tablets comprising low surface area calcium phosphates
JP4925835B2 (ja)	2007-01-12	2012-05-09	日東電工株式会社	物質検知センサ
US20180325813A1 (en)	2015-11-07	2018-11-15	Ftf Pharma Private Limited	Oral solution of ace inhibitors
GB2595203A (en)	2020-03-03	2021-11-24	Alkaloid Ad Skopje	Formulation
CN119746022A (zh) *	2024-12-27	2025-04-04	江苏天士力帝益药业有限公司	一种赖诺普利氢氯噻嗪药物组合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4517179A (en) *	1983-04-29	1985-05-14	Pennwalt Corporation	Rapid dissolving, uniform drug compositions and their preparation
US4675188A (en) *	1985-08-02	1987-06-23	Stauffer Chemical Company	Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4707361A (en) *	1985-08-02	1987-11-17	Stauffer Chemical Company	Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
HU222489B1 (hu) †	1990-07-25	2003-07-28	Novartis Ag.	Stabilizált gyógyszerkészítmények és eljárás az előállításukra
US6210715B1 (en) *	1997-04-01	2001-04-03	Cap Biotechnology, Inc.	Calcium phosphate microcarriers and microspheres
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets

2001
- 2001-09-24 US US09/962,429 patent/US6462022B1/en not_active Expired - Lifetime
2002
- 2002-09-20 PT PT02758654T patent/PT1432407E/pt unknown
- 2002-09-20 GB GB0311750A patent/GB2384429B/en not_active Expired - Fee Related
- 2002-09-20 ES ES02758654T patent/ES2236561T5/es not_active Expired - Lifetime
- 2002-09-20 EP EP02758654A patent/EP1432407B2/en not_active Expired - Lifetime
- 2002-09-20 JP JP2003530259A patent/JP4084749B2/ja not_active Expired - Fee Related
- 2002-09-20 AT AT02758654T patent/ATE290370T1/de active
- 2002-09-20 DE DE60203192T patent/DE60203192T3/de not_active Expired - Lifetime
- 2002-09-20 WO PCT/GB2002/004292 patent/WO2003026622A1/en not_active Ceased
- 2002-09-20 DK DK02758654T patent/DK1432407T3/da active

Also Published As

Publication number	Publication date
GB2384429A (en)	2003-07-30
JP4084749B2 (ja)	2008-04-30
US6462022B1 (en)	2002-10-08
ES2236561T3 (es)	2005-07-16
DE60203192T2 (de)	2006-04-13
PT1432407E (pt)	2005-05-31
GB2384429B (en)	2004-04-14
WO2003026622A1 (en)	2003-04-03
JP2005504803A (ja)	2005-02-17
EP1432407B1 (en)	2005-03-09
DE60203192D1 (de)	2005-04-14
EP1432407B2 (en)	2012-08-01
DE60203192T3 (de)	2012-12-27
GB0311750D0 (en)	2003-06-25
ATE290370T1 (de)	2005-03-15
EP1432407A1 (en)	2004-06-30
ES2236561T5 (es)	2012-10-30

Similar Documents

Publication	Publication Date	Title
MX9404762A (es)	1995-01-31	Composiciones para inhalacion y proceso para su preparacion.
MY118371A (en)	2004-10-30	Tetrahydrolipstatin containing compositions
DE59409568D1 (de)	2000-11-30	Wirkstoffe und gas enthaltende mikropartikel
HRP20000434B1 (en)	2010-12-31	Celecoxib compositions
ATE271383T1 (de)	2004-08-15	Pulverformulierung zur inhalation
WO2001041770A3 (en)	2001-11-22	Nanoparticulate eplerenone compositions
PL360254A1 (en)	2004-09-06	Pharmaceutical compositions
IL99515A0 (en)	1992-08-18	Calcium uptake inhibitors
CA2445519A1 (en)	2002-11-07	Method for manufacturing a low dose pharmaceutical composition
ATE330943T1 (de)	2006-07-15	Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
GB9913095D0 (en)	1999-08-04	Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
ATE254922T1 (de)	2003-12-15	Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
CA2163218A1 (en)	1994-11-24	New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
ES2160622T3 (es)	2001-11-16	Composicion a base de biopolimeros de hidratacion rapida.
DE60203192D1 (de)	2005-04-14	Zubereitungen mit lisinopril und ungemahlenem dcpd
MX2008001645A (es)	2008-04-07	Composiciones de fexofendina en suspension farmaceutica oral.
FI962056A0 (fi)	1996-05-15	Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
DE60312670D1 (de)	2007-05-03	Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
ATE344026T1 (de)	2006-11-15	Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant
MD2722B2 (ro)	2005-03-31	Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei
CA2344686A1 (en)	2000-04-27	High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
ES2174734A1 (es)	2002-11-01	Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
ATE44467T1 (de)	1989-07-15	Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
AU8452791A (en)	1992-03-26	1-phenyl-3-aryl-2-propyne-1-ones
CA2373827A1 (en)	2000-11-23	Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines